Digg icon reddit icon Stumbleupon icon
Print Email     Print Edition Stories

Friday, March 19, 2010

Volpa named to NuOrtho’s board

By Mass High Tech staff

NuOrtho Surgical Inc. has named Darik Volpa, CEO of Understand.com, to its board of directors.

Jeffrey Morrill, CEO of Fall River-based NuOrtho Surgical, noted that Volpa has led his privately held company to seven straight years of record sales growth.

Volpa founded Understand.com, a Reno, Nev.-based provider of medical content that helps healthcare professionals and companies better communicate diseases, conditions and procedures to patients using 3D animation.

Volpa previously worked with Stryker Corp., a $6 billion medical device company, where he served in various sales and marketing roles for nine years.

NuOrtho Surgical manufactures surgical instruments that enable tissue preservation in the orthopedic arena to improve patient outcomes. NuOrtho has three primary product platforms for preserving healthy tissue: Soft Tissue Treatment, Agent Delivery and Bone Fusion. NuOrtho’s first product launch will be Ceruleau, a product for soft tissue treatment in knee procedures for cartilage.

Earlier this month, NuOrtho Surgical said it had added Ian McRury as chief scientific officer .

Comments

If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.

Digg icon reddit icon Stumbleupon icon
Contact Editor Latest News

Tech Pulse Poll

What's your level of interest in Pinterest?



View Results

Stay Informed
Check which newsletter you'd like to receive.
TechFlash (Daily)
BioFlash (Daily)
GreenFlash (Weekly)
Startup Report (Weekly)
Breaking news, MHT events, local announcements
RSS feeds
Your email:

Affiliate publications: ACBJ.com, Boston Business Journal, Bizjournals.com, Portfolio.com, Wired.com

Web Site Developed by Neptune Web, Inc.

Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement and Privacy Policy. About our ads.